SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE Relative Valuation

-9423.0%
Upside

As of 2024-03-02, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (28.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -9423.0%.

The range of the Relative Valuation is (28.43) - (29.47) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.4x - 28.0x 25.5x
Forward P/E multiples 19.5x - 24.3x 21.7x
Fair Price (28.43) - (29.47) (28.65)
Upside -9351.8% - -9691.6% -9423.0%
0.31 USD
Stock Price
(28.65) USD
Fair Price

SRNE Relative Valuation - Historical P/E Data

Date P/E